Skip to content

A clinical trial utilizing Homoeopathic medicines for Pityriasis alba in Pediatric patients.

Experimental clinical study of Pityriasis alba with Homoeopathic medicines in Pediatrics. - nil

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064065
Enrollment
102
Registered
2024-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L305- Pityriasis alba

Interventions

Intervention1: Homoeopathic medicines: Indicated Homoeopathic Medicines will be prescribed as, 6 pills early morning in empty stomach orally for 3 days and followed up after 15 days. if required the m

Sponsors

Dr Jesheela
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The study includes all subjects in the Pediatric age ranges 3 to 16years with Pityriasis Alba. 2. Regardless of gender or socio economic status, the subjects will be chosen.

Exclusion criteria

Exclusion criteria: 1.In immunocompromised children and subjects who are currently receiving therapy for any other chronic or systemic condition 2.Patients of 16 years of age will be excluded. 3.Subjects not willing to participate or not ready to give informed consent & assent will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
After 6 months Of administration of Homoeopathic medicines pityriasis alba is assessedTimepoint: After administration of homeopathic medicines every 2 weeks in follow up pityriasis alba is assessed

Secondary

MeasureTime frame
After 3months of administration of Homoeopathic Medicine Pityriasis alba is assessed.Timepoint: After Every 2weeks in follow up Pityriasis alba is assessed

Countries

India

Contacts

Public ContactDr Mahendra H Goushal

Department of pediatrics SKHMC Beed

draage.md@gmail.com9422744892

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026